batrafen
sanofi-aventis new zealand limited - ciclopirox olamine 1%{relative} - topical cream - 1% w/w - active: ciclopirox olamine 1%{relative}
batrafen
sanofi-aventis new zealand limited - ciclopirox olamine 1%{relative} - topical solution - 1% w/v - active: ciclopirox olamine 1%{relative}
intal forte
sanofi-aventis new zealand limited - sodium cromoglicate 5mg equivalent to 3.5211% w/w; ; - aerosol inhaler, metered dose - 5 mg/dose - active: sodium cromoglicate 5mg equivalent to 3.5211% w/w excipient: apaflurane macrogol 600 povidone - intal forte 5 mg cfc-free is indicated for the preventive treatment of bronchial asthma (which may be due to allergy, exercise, cold air or chemical irritants) in adults and children.
tilade cfc-free
sanofi-aventis new zealand limited - nedocromil sodium 1.4085%{relative} (2 mg/dose); - aerosol inhaler, metered dose - 2 mg/dose - active: nedocromil sodium 1.4085%{relative} (2 mg/dose) excipient: apaflurane macrogol 600 menthol povidone - tilade cfc-free is indicated in the treatment of bronchial asthma (whether extrinsic or intrinsic in nature, and including asthmatic bronchitis, late onset asthma, exercise induced asthma, and bronchospasm provoked by a variety of stimuli such as cold air, inhaled allergens, atmospheric pollutants and other irritants). tilade cfc-free is intended for regular prophylactic treatment and not for symptomatic relief. in the management of asthma, tilade cfc-free improves pulmonary function, reduces the frequency and severity of attacks and reduces bronchospasm, cough and bronchial hyper-responsiveness. in patients already receiving treatment for their asthma, tilade cfc-free can be given in addition to all existing therapies and will in many cases provide added therapeutic benefit. having established this benefit of tilade cfc-free, it may be possible to gradually reduce or eliminate concomitant therapy.
apidra solostar 100 unitsml solution for injection in a pre-filled pen
sanofi-aventis singapore pte. ltd. - insulin glulisine - injection, solution - 3.49 mg (100 units) - insulin glulisine 3.49 mg (100 units)
lantus solostar 100 unitsml solution for injection in a pre-filled pen
sanofi-aventis singapore pte. ltd. - insulin glargine - injection, solution - 100 iu/ml - insulin glargine 100 iu/ml
lyxumia solution for injection in pre-filled pen 10mcg (50mcgml)
sanofi-aventis singapore pte. ltd. - lixisenatide - injection, solution - 50mcg/ml - lixisenatide 50mcg/ml
lyxumia solution for injection in pre-filled pen 10mcg and 20mcg (50mcgml and 100mcgml)
sanofi-aventis singapore pte. ltd. - (10mcg) lixisenatide; (20mcg) lixisenatide - injection, solution - 0.05mg/ml - (10mcg) lixisenatide 0.05mg/ml; (20mcg) lixisenatide 0.1mg/ml
lyxumia solution for injection in pre-filled pen 20mcg (100mcgml)
sanofi-aventis singapore pte. ltd. - lixisenatide - injection, solution - 100mcg/ml - lixisenatide 100mcg/ml
apidra 100 unitsml solution for injection in vial
sanofi-aventis singapore pte. ltd. - insulin glulisine - injection, solution - 3.49 mg - insulin glulisine 3.49 mg